Table 1 Demographic features, paraoxonase activity and biochemical parameters in controls and lung cancer patient groups
From: Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
| Â | Control group (n = 39) | Patient group (n = 39) | P value |
|---|---|---|---|
Age (year) | 64.0 ± 8.6 | 64.4 ± 8.9 | 0.861 |
Cigarette smoking (%) | 64.1 | 89.7 | 0.014 |
Total cholesterol (mg/dl) | 193.2 ± 48.5 | 165.1 ± 50 | 0.014 |
LDL cholesterol (mg/dl) | 128.8 ± 35.3 | 116 ± 42.4 | 0.152 |
HDL cholesterol (mg/dl) | 41.7 ± 10.9 | 34.9 ± 20.8 | 0.074 |
VLDL cholesterol (mg/dl) | 32 ± 16.3 | 29.3 ± 11.5 | 0.393 |
Triglyceride (mg/dl) | 160.8 ± 81.7 | 141.3 ± 53.9 | 0.219 |
PON1 (U/mL) | 395.8 ± 116.6 | 252.7 ± 104.4 | 0.001 |
ARE (U/L) | 167.7 ± 45 | 137.4 ± 57.6 | 0.018 |
PON1/ARE | 2.4 ± 0.6 | 2.0 ± 0.9 | 0.008 |
PON/HDL | 9.8 ± 2.9 | 8.1 ± 2.9 | 0.009 |